Magazine Article | April 1, 2021

How Small Biotechs Can Implement Pharmacovigilance Systems

Source: Life Science Leader

By Steve Knowles

When it comes to implementing strong pharmacovigilance (PV) practices at your company, there is a variety of components and capabilities that will be necessary. Having worked in this space for most of my pharma industry career, I know it can be incredibly difficult to understand the intricacies of integrating these processes.

Pharmacovigilance is a catchall word used to describe anything that falls under the drug safety umbrella — detection, assessment, understanding, and prevention of adverse effects that may be associated with a medicine. It ensures that patients experience as little harm as possible when taking medications (clinically validated ones or otherwise).

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader